Collagen-Binding IL-12-Armoured STEAP1 CAR-T Cells Reduce Toxicity and Treat Prostate Cancer in Mouse Models

Researchers showed that collagen-binding domain-fused IL-12 secreted from CAR-T cells to target human six transmembrane epithelial antigen of prostate 1 (STEAP1) is retained within murine prostate tumors.